Li Zeng

922 total citations
38 papers, 669 citations indexed

About

Li Zeng is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Li Zeng has authored 38 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Li Zeng's work include Trypanosoma species research and implications (5 papers), Skin Protection and Aging (4 papers) and Ferroptosis and cancer prognosis (3 papers). Li Zeng is often cited by papers focused on Trypanosoma species research and implications (5 papers), Skin Protection and Aging (4 papers) and Ferroptosis and cancer prognosis (3 papers). Li Zeng collaborates with scholars based in China, United States and Belgium. Li Zeng's co-authors include Donald A. Cohen, Alan M. Kaplan, Jiayou Zhang, Sandra H. Burnett, Susan C. Straley, Natasha Kyprianou, Motohiro Takeya, Stefan Magez, Yann G.‐J. Sterckx and Julie Goossens and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Li Zeng

32 papers receiving 659 citations

Peers

Countries citing papers authored by Li Zeng

Since Specialization

Citations

This map shows the geographic impact of Li Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zeng more than expected).

Fields of papers citing papers by Li Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zeng. The network helps show where Li Zeng may publish in the future.

Co-authorship network of co-authors of Li Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zeng. A scholar is included among the top collaborators of Li Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zeng. Li Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the Effect of Exosomes From Adipose Derived Stem Cells on Changes in GSH/ROS Levels During Skin Photoaging 2025 ·Photodermatology Photoimmunology & Photomedicine ·Yiping Wang, (unknown), (unknown), Nian Chen, Yihao Wang, (unknown), Chiyu Jia, Li Zeng	1
2	Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review 2025 ·Frontiers in Immunology ·(unknown), Li Zeng, (unknown), Hong Liao, Shukui Zhou	0
3	A CRISPR-Cas-based recombinase polymerase amplification assay for ultra-sensitive detection of active Trypanosoma brucei evansi infections 2025 ·Frontiers in Molecular Biosciences ·(unknown), Li Zeng, (unknown), Benoı̂t Stijlemans, Peter Geldhof, Stefan Magez	3
4	CDKN3 as a key regulator of G2M phase in triple‐negative breast cancer: Insights from multi‐transcriptomic analysis 2025 ·IUBMB Life ·(unknown), (unknown), Jiayu Zheng, (unknown), (unknown), Junxiang Wang, (unknown), Xiucheng Li, Li Zeng, Kena Song, Chunyan Liu, (unknown), Qinan Yin, Xuewei Zheng	0
5	Abstract 2140: Beyond antibodies and CAR-T: CC312, a first-in-class, anti-CD19, anti-CD3, anti-CD28 trispecific antibody in treatment with relapsed and/or refractory B-cell malignancies 2025 ·Cancer Research ·(unknown), Xiaofang Zhang, Ruixia Zhang, Zhen Jing, (unknown), Fangfang Pan, Beibei Zheng, Ruixue Dai, Yingying Yang, Li Zeng	1
6	Epitranscriptomic orchestrations: Unveiling the regulatory paradigm of m6A, A‐to‐I editing, and m5C in breast cancer via long noncoding RNAs and microRNAs 2024 ·Cell Biochemistry and Function ·Qinan Yin, (unknown), (unknown), Li Zeng, Zhe Du, Yun Xue, (unknown), Xuewei Zheng	3
7	The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment 2024 ·Journal of Translational Medicine ·Qinan Yin, (unknown), (unknown), (unknown), Junxiang Wang, (unknown), Longfei Mao, Li Zeng, Xin Xiong, (unknown), (unknown), Xuewei Zheng	12
8	Biological effects and mechanisms of dietary chalcones: latest research progress, future research strategies, and challenges 2024 ·Food & Function ·Yun Zhang, Shuangjiao Sun, Li Zeng	3
9	Automated Visual Inspection for Precise Defect Detection and Classification in CBN Inserts 2024 ·Sensors ·Li Zeng, Feng Wan, (unknown), (unknown)	1
10	Recent Progress in the Detection of Surra, a Neglected Disease Caused by Trypanosoma evansi with a One Health Impact in Large Parts of the Tropic and Sub-Tropic World 2023 ·Microorganisms ·(unknown), (unknown), Li Zeng, Magdalena Radwanska, Stefan Magez	7
11	Mesenchymal stem cell‐derived exosomes and skin photoaging: From basic research to practical application 2023 ·Photodermatology Photoimmunology & Photomedicine ·Yihao Wang, Xu Shen, (unknown), (unknown), Yiping Wang, (unknown), Nian Chen, Li Zeng	8
12	Optimization Method of power grid data fusion for High Proportion New Energy System 2022 ·(unknown), (unknown), (unknown), Jing Zhang, Li Zeng	0
13	Development of a recombinase polymerase amplification lateral flow assay for the detection of active Trypanosoma evansi infections 2020 ·PLoS neglected tropical diseases ·Li Zeng, (unknown), Julie Goossens, Benoı̂t Stijlemans, Yann G.‐J. Sterckx, Stefan Magez	21
14	Engineered resistance to Nosema bombycis by in vitro expression of a single-chain antibody in Sf9-III cells 2018 ·PLoS ONE ·(unknown), Jie Chen, Bin Sun, Rong Zheng, Boning Li, Li Zeng, (unknown), Junhong Wei, Guoqing Pan, Chunfeng Li, Zeyang Zhou	31
15	IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines 2010 ·Cytokine ·Li Zeng, (unknown), Jiayou Zhang, Alan M. Kaplan, Donald A. Cohen	45
16	Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder 2005 ·Urology ·(unknown), Chad A. LaGrange, Li Zeng, Bonnie Mitchell, William T. Conner, Natasha Kyprianou	11
17	Apoptosis incidence and protein expression of p53, TGF-β receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate1 1Accepted for publication 0, 2003. 2004 ·Human Pathology ·Li Zeng, Randall G. Rowland, Subodh M. Lele, Natasha Kyprianou	40
18	Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention 2004 ·Prostate Cancer and Prostatic Diseases ·Li Zeng, Natasha Kyprianou	12
19	Interspecies reactivities of anti-human macrophage monoclonal antibodies to various animal species. 1996 ·Journal of Histochemistry & Cytochemistry ·Li Zeng, Motohiro Takeya, (unknown), Akitoshi Nagasaki, Kei Takahashi	35
20	AM-3K, A NOVEL MONOCLONAL ANTIBODY SPECIFIC FOR TISSUE MACROPHAGES AND ITS APPLICATION TO PATHOLOGICAL INVESTIGATION 1996 ·The Journal of Pathology ·Li Zeng, Motohiro Takeya, Kiyoshi Takahashi	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact